Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2003
08/28/2003WO2003071281A2 Estrogen receptor interaction with a transcription factor
08/28/2003WO2003071275A1 Ultraphobic surface having a multitude of reversibly producible hydrophilic and/or oleophilic areas
08/28/2003WO2003071274A1 Use of ultraphobic surfaces having a multitude of hydrophilic areas for analyzing samples
08/28/2003WO2003071271A1 Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or produrgs thereof
08/28/2003WO2003071270A2 Screening method
08/28/2003WO2003071268A2 Method for discovering pharmacologically active substances
08/28/2003WO2003071267A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
08/28/2003WO2003071252A2 Methods for analysis of molecular events
08/28/2003WO2003071140A2 Cell viability detection using electrical measurements
08/28/2003WO2003070986A1 Removal of nucleic acid contaminants
08/28/2003WO2003070985A1 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
08/28/2003WO2003070984A1 Methods and reagents for detecting target binding by nucleic acid ligands
08/28/2003WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
08/28/2003WO2003070980A2 Nucleic acid quantification
08/28/2003WO2003070979A2 Materials and methods relating to cancer diagnosis
08/28/2003WO2003070978A1 Method for identifying side-effect relevant genetic marker profiles
08/28/2003WO2003070977A2 Method for detecting single nucleotide polymorphisms
08/28/2003WO2003070976A2 Methods for determining the influence of protein binding on antiretroviral activity
08/28/2003WO2003070974A2 Mismatch repair detection
08/28/2003WO2003070967A2 Highly homogeneous molecular markers for electrophoresis
08/28/2003WO2003070966A2 RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070965A2 The eaat2 promoter and uses thereof
08/28/2003WO2003070964A2 Methods for searching polynucleotide probe targets in databases
08/28/2003WO2003070951A1 Arteriosclerosis-specific gene and utilization thereof
08/28/2003WO2003070943A1 Methods for two-dimensional conformation-dependent separation of non-circular nucleic acids
08/28/2003WO2003070938A1 Gene expression data analyzer, and method, program and recording medium for gene expression data analysis
08/28/2003WO2003070937A1 Protein having osteogenic protein-binding region and gene encoding the same
08/28/2003WO2003070935A1 PRIMERS FOR NUCLEIC ACID AMPLIFICATION IN DETECTING HOUSEKEEPING GENE mRNA AND TEST METHOD USING THESE PRIMERS
08/28/2003WO2003070934A1 METHOD OF JUDGING GENOTYPE OF REGION AROUND PLANT sd-1 GENE AND METHOD OF EXAMINING SEMI-DWARF CHARACTERISTIC OF PLANT USING THE JUDGMENT METHOD
08/28/2003WO2003070926A1 New nucleotide sequences encoding human phb: polyprenyltransferase polypeptides
08/28/2003WO2003070922A1 Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
08/28/2003WO2003070907A2 Novel fungal lipase
08/28/2003WO2003070901A2 Heat stable mutants of starch biosynthesis enzymes
08/28/2003WO2003070898A2 Selective extraction of dna from groups of cells
08/28/2003WO2003070894A2 A non-invasive diagnostic test utilizing histone modification markers
08/28/2003WO2003070891A2 Method of determining adenovirus particle concentration
08/28/2003WO2003070889A2 Prostate specific genes and the use thereof in design or therapeutics
08/28/2003WO2003070883A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
08/28/2003WO2003070882A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
08/28/2003WO2003070879A2 Cyclin dependent kinase 5 phosphorylation of disabled 1 protein
08/28/2003WO2003070878A2 Antisense modulation of hematopoietic cell protein tyrosine kinase expression
08/28/2003WO2003070877A2 Nucleic acid amplification
08/28/2003WO2003070876A2 Method for attaching nucleic acid molecules to electrically conductive surfaces
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070768A2 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
08/28/2003WO2003070766A2 A transducer of mas signalling
08/28/2003WO2003070746A2 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua
08/28/2003WO2003070700A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
08/28/2003WO2003070265A2 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
08/28/2003WO2003070256A1 Hyaluronic acid mediated adenoviral transduction
08/28/2003WO2003070171A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003WO2003070162A2 Par-3 compounds for therapy and diagnosis and methods for using same
08/28/2003WO2003070082A2 Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer
08/28/2003WO2003069999A1 Proteins for helicobacter diagnosis
08/28/2003WO2003069979A2 Plant preparations
08/28/2003WO2003062273A3 Modulator of the notch signalling pathway and use thereof in medical treatment
08/28/2003WO2003060121A3 Compositions and methods relating to gastric specific genes and proteins
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003048314A3 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
08/28/2003WO2003044213A3 Cell and tissue arrays and microarrays and methods of use
08/28/2003WO2003044177A3 Multiplex pcr
08/28/2003WO2003034037A3 Apparatus and method for destacking articles
08/28/2003WO2003031611A3 Phagemid display system
08/28/2003WO2003020912A3 Novel clark protein and nucleic acid molecules and uses therefor
08/28/2003WO2003020905A3 Nucleic acid compositions conferring disease resistance
08/28/2003WO2003020757A3 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
08/28/2003WO2003018831A3 Primers and method for the genotyping of snps by multiplex pcr
08/28/2003WO2003016867A3 Method and quantification assay for determining c-kit/scf/pakt status
08/28/2003WO2003016522A3 Methods and compounds for the targeting of protein to exosomes
08/28/2003WO2003014321A3 Compositions and methods for modulation of darpp-32 phosphorylation
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2003012132A3 Screening method for inhibitors of folate synthesis pathway enzymes
08/28/2003WO2003012046A3 Stk15 (stk6) gene polymorphism and methods of determining cancer risk
08/28/2003WO2003006687A3 Novel target genes for diseases of the heart
08/28/2003WO2003002766A3 Method for detection of foot-and-mouth disease virus
08/28/2003WO2002103047A3 Genomic mapping method
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002099383A3 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
08/28/2003WO2002097051A3 Protein arrays and methods and systems for producing the same
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002095413A3 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
08/28/2003WO2002093173A3 Screening method using pim1-kinase or pim3-kinase
08/28/2003WO2002088382A3 Method for analysing nucleic acid chains
08/28/2003WO2002088362A3 Regulation of human prostaglandin-f synthase 1-like protein
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
08/28/2003WO2002081687A3 Yeast genes that affect viral replication
08/28/2003WO2002079785A3 Phosphoprotein target for insulin and its antagonists
08/28/2003WO2002074048A8 P-glycoproteins and uses thereof
08/28/2003WO2002070735A3 Method for the amplification and detection of dna using a transcription based amplification
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002068687A3 Function and application of tob gene in central nervous system of mammal
08/28/2003WO2002066660A3 Method for identifying herbicidally active substances
08/28/2003WO2002061147A3 Self-complementary molecular probe and methods using it
08/28/2003WO2002056030A3 Method and device for collecting and stabilizing a biological sample
08/28/2003WO2002055655A8 Metylococcus capsulatus genes and dna array for the determination of gene expression in metylococcus capsulatus
08/28/2003WO2002054073A3 Latent human tuberculosis model, diagnostic antigens, and methods of use
08/28/2003WO2002053773A3 Method for determining skin stress or skin ageing in vitro
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002046467A3 Gene expression profiling of primary breast carcinomas using arrays of candidate genes
08/28/2003WO2002044736A3 Diagnosis and treatment of epidermal or skin diseases
1 ... 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 ... 3003